1Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology, 1968,18:671-680.
2Katsuno M, Adachi H, Doyu M, et al. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat Med, 2003,9 : 768- 773.
5Adachi H, Katsuno M, Minamiyama M, et al. Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients. Brain ,2005,128:659-670.
6Sinnreich M, Sorenson E J, Klein CJ. Neurologic course, endocrine dysfunction and triplet repeat size in spinal bulbar muscular atrophy. Can J Neurol Sci,2004,31:375-382.
7Banno H, Katsuno M, Suzuki K, et al. Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. Ann Neurol, 2009,65:140-150.
4Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology, 1968,18 : 671-680.
5Lumbroso S, Lobaccaro JM, Vial C, et al. Molecular analysis of the androgen receptor gene in Kennedy' s disease. Report of two families and review of the literature. Horm Res, 1997, 47:23-29.
6Atsuta N, Watanabe H, Ito M, et al. Nature history of spinal and bulbar muscular atrophy ( SBMA ) : a study of 223 Japanese patients. Brain, 2006, 129 Pt 6:1446-1455.
7Pachatz C, Terracciano C, Desiato MT, et al. Upper motor neuron involvement in X-linked recessive bulbospinal muscular atrophy. Clin Neurophysiol, 2007, 118 : 262-268.
8Katsuno M, Adachi H, Tanaka F, et al. Spinal and bulbar muscular atrophy: ligand-dependent pathogenesis and therapeutic perspectives. J Mol Med, 2004, 82: 298-307.
9Sorenson E J, Klein CJ. Elevated creatine kinase and transaminases in asymptomatic SBMA. Amyotmph Lateral Scler, 2007, 8 : 62-64.
10Tomik B, Partyka D, Sulek A, et al. A phenotypic-genetic study of a group of Polish patients with spinal and bulbar muscular atrophy. Amyotroph Lateral Scler, 2006, 7: 72-79.
3Bttrgunder JM, Sehoels L, Baets .1, et al. EFNS guidelines for the molecular diagnosis of neurogenetic disorders: motoneuron, peripheral nerve and muscle disorders [J]. Eur J Neurol, 2011, 18 (2): E20-207.
4Sorarfa G, D'ascenzo C, Polo A, et al. Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females[J]. J Neurol Sci, 2008, 264(1/2): 100-5.
5Banno H, Katsuno M, Suzuki K, et al. Phase 2 trial of leuprorelin inpatients with spinal and bulbar muscular atrophy EJ. Ann Neurol, 2009, 65(2): 140-50.
6Hardiman O, Van den Berg LH, kieman MC. clinical diagnosis and management of amyotrophic lateral sclerosis [J]. Nat Rev Neurol, 2011, 7(11): 639-49.
7Hama T, Hirayama M, Hara T, et al. Discrimination of spinal and bulbar muscular atrophy from amyotrophic lateral sclerosis using sensory nerve action potentials [J]. Muscle Nerve, 2012, 45 (2): 169-74.
8Eisen A, Kuwabara S. The split hand syndrome in amyotrophic lateral sclerosis [J]. J Neurol Neurosurg Psychiatry, 2012, 83 (4): 399-403.
9Salameh JS, Atassi N, David WS. SOD1 (A4V)-mediated ALS presenting with lower motor neuron facial diplegia and unilateral vocal cord paralysis[J]. Muscle Nerve, 2009, 40(5): 880-2.
10Fratta P, Hanna MG, Fisher EM. An unusual presentation for sodl-als: isolated facial diplegia [J]. Muscle Nerve, 2013, 48 (6): 994-5.
